Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.4788
-0.0692 (-12.63%)
At close: Oct 16, 2026, 4:00 PM EDT
0.4861
+0.0073 (1.52%)
Pre-market: Oct 19, 2026, 7:30 AM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $1.89 million as of October 16, 2026. It is the 48,186th most valuable company in the world and the 6,492nd biggest in the United States. Its market cap has decreased by 65.64% in one year.
Market Cap
1.89M
Enterprise Value
-3.86M
1-Year Change
-65.64%
Global Rank
Country Rank
#6,492 United States
Category
ChartMarket Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $624.51M to $1.89M, a decrease of -99.70%. That is a compound annual growth rate of -71.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 1.89M | -22.05% |
| Dec 31, 2025 | 2.43M | -53.56% |
| Dec 31, 2024 | 5.22M | 43.70% |
| Dec 29, 2023 | 3.64M | -78.64% |
| Dec 30, 2022 | 17.02M | -97.28% |
| Feb 18, 2022 | 624.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XORTX Therapeutics | 2.25M |
| PMGC Holdings | 2.24M |
| GeoVax Labs | 2.17M |
| Propanc Biopharma | 2.17M |
| Kairos Pharma | 2.04M |
| Oragenics | 1.96M |
| BioRestorative Therapies | 1.96M |
| Revelation Biosciences | 1.93M |